Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-05

Clinical Trial Update: Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update investigates whether blood platinum levels correlate with neurotoxicity in patients receiving oxaliplatin for gastrointestina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eloxatin (oxaliplatin)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Cancer | Phase 4 | Status: UNKNOWN